The French-Swedish Life Science Days in Paris gathers executives from international biotech, pharmaceutical & diagnostic companies and venture capital. The meeting offers networking opportunities, company presentations and panel discussions.
“The event is important for Biovica since we are now entering a new phase of collaborations with pharmaceutical companies and academia. The French-Swedish Life Science Day is great way for us to present our capabilities and further expand our growing network within the industry.” says Anders Rylander CEO Biovica.
Biovica was founded in 2009 and has built an extensive portfolio of clinical trials for it’s DiviTum technology through international collaboration with academia and the pharmaceutical industry. As of today DiviTum has 10 peer-reviewed publications, 13 on-going clinical trials and a promising pipeline of new studies and projects.